Wednesday, October 14, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleSeeking Alpha· July 28, 2026

D-Wave Quantum dips 10%, moderating previous day's rally

View original at seekingalpha.com
D-Wave Quantum dips 10%, moderating previous day's rally [Artificial Intelligence, concept CPU - quantum computing] MF3d/E+ via Getty Images D-Wave Quantum (QBTS [https://seekingalpha.com/symbol/QBTS]) shares fell approximately 10% on Tuesday, pulling back after a 20% surge the previous session…
Opening lines of the source · Seeking Alpha · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • QBTS trades at a stretched 171x price-to-sales multiple versus peers, with projected 2026 revenue near $35 million and a fair value estimate of $9.50 per share, implying roughly 40% downside from current levels, citing a delayed technology roadmap and D-Wave's reliance on SkyWare amid IonQ's pending acquisition of that supplier.

    60% confidence
  • D-Wave now offers quantum-as-a-service rather than requiring customers to purchase machines outright, though annealing addresses a specific subset of optimization problems.

    60% confidence
  • Their original 3-to-5-year investment thesis on D-Wave may need to extend to 7-to-10 years before quantum computing achieves meaningful commercial traction.

    60% confidence
  • Questioned the substance of the AT&T announcement, noting that no contract value or timeline was disclosed.

    60% confidence
  • The stock could rise further in the near term, but meaningful revenue generation remains the key missing ingredient.

    60% confidence
  • Sold their position after profiting from the AT&T-driven rally, expecting the enthusiasm to fade and characterizing quantum stocks as high-beta plays.

    60% confidence
  • D-Wave's dual-platform approach spanning both annealing and gate-model quantum computing is a competitive differentiator and strategic advantage over single-method peers.

    60% confidence
  • Cited the 171x price-to-sales ratio as a reason for caution on capital allocation to QBTS.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com